A detailed history of Fi3 Financial Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fi3 Financial Advisors, LLC holds 14,862 shares of LLY stock, worth $13.2 Million. This represents 5.93% of its overall portfolio holdings.

Number of Shares
14,862
Previous 14,711 1.03%
Holding current value
$13.2 Million
Previous $11.4 Million 17.57%
% of portfolio
5.93%
Previous 5.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $109,455 - $137,265
151 Added 1.03%
14,862 $13.5 Million
Q1 2024

May 06, 2024

SELL
$592.2 - $792.28 $69,879 - $93,489
-118 Reduced 0.8%
14,711 $11.4 Million
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $16,280 - $19,193
31 Added 0.21%
14,829 $8.64 Million
Q3 2023

Nov 09, 2023

BUY
$434.7 - $599.3 $55,206 - $76,111
127 Added 0.87%
14,798 $7.95 Million
Q2 2023

Aug 08, 2023

BUY
$350.74 - $468.98 $8,067 - $10,786
23 Added 0.16%
14,671 $6.88 Million
Q1 2023

May 04, 2023

SELL
$310.63 - $364.82 $21,744 - $25,537
-70 Reduced 0.48%
14,648 $5.03 Million
Q4 2022

Feb 06, 2023

BUY
$321.55 - $374.67 $15,434 - $17,984
48 Added 0.33%
14,718 $5.38 Million
Q3 2022

Nov 09, 2022

SELL
$296.48 - $337.87 $41,803 - $47,639
-141 Reduced 0.95%
14,670 $4.74 Million
Q2 2022

Aug 08, 2022

BUY
$278.73 - $327.27 $24,249 - $28,472
87 Added 0.59%
14,811 $4.78 Million
Q1 2022

May 02, 2022

SELL
$234.69 - $291.66 $3,520 - $4,374
-15 Reduced 0.1%
14,724 $4.22 Million
Q4 2021

Jan 27, 2022

BUY
$224.85 - $279.04 $39,348 - $48,832
175 Added 1.2%
14,739 $4.07 Million
Q3 2021

Nov 16, 2021

SELL
$221.6 - $272.71 $41,660 - $51,269
-188 Reduced 1.27%
14,564 $3.37 Million
Q2 2021

Aug 04, 2021

SELL
$180.55 - $233.54 $1.07 Million - $1.38 Million
-5,904 Reduced 28.58%
14,752 $3.78 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $3.39 Million - $4.39 Million
20,656 New
20,656 $3.86 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $843B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fi3 Financial Advisors, LLC Portfolio

Follow Fi3 Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fi3 Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fi3 Financial Advisors, LLC with notifications on news.